carteolol has been researched along with Cancer Syndromes, Hereditary in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, MN | 1 |
| Zhang, M | 1 |
| Xu, Y | 1 |
| Wang, M | 1 |
| Yuan, SM | 1 |
1 other study available for carteolol and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Individualized Treatment for Infantile Hemangioma.
Topics: Administration, Cutaneous; Administration, Oral; Betamethasone; Carteolol; Female; Glucocorticoids; | 2018 |